Previda®-DX
Gene Disorders (PGT-M)
Chromosomal Rearrangements (PGT-SR)
Menu
Previda®-DX is a preimplantation genetic test that is designed to screen embryos for inherited genetic disorders. For couples with a family history of an inherited disease, the customized test detects specific monogenic/single gene defects (PGT-M) and chromosomal structural rearrangements (PGT-SR) in embryos. By checking for these abnormalities, Previda®-DX helps your IVF team select a healthy embryo for transfer. PGT-M and PGT-SR are both formerly known as PGD or preimplantation genetic diagnosis.
If a single gene disorder runs in your family, you can learn your child’s risk of inheriting the condition before implantation through PGT-M.
Chromosomal structural rearrangements may explain recurrent miscarriages. Screen the embryo for these abnormalities prior to transfer using our PGT-SR.
Your results can help your physician select an embryo that is free of an inherited genetic defect or unbalanced rearrangement, increasing your chance of achieving a healthy pregnancy.
At Progenesis, patients are our highest priority.
We are happy to address any of your questions or concerns.
Progenesis Inc.
Address: 4150 Regents Park Row,
Suite 245,
La Jolla, CA 92037
Phone: (858) 257-2122
Fax: (888) 810-6079
Progenesis is a San Diego based company that develops and offers genetic testing services for patients throughout their family planning journey. Progenesis was the first company in the U.S. to offer Next Generation Sequencing (NGS) for preimplantation genetic testing. Through optimization of the NGS platform, Progenesis confidently maintains the most accurate testing in the IVF field with the lowest rate of mosaicism.
